Bristol-Myers Squibb and Pfizer announced that the FDA has accepted for review a supplemental New Drug Application (sNDA) for Eliquis (apixaban), for prophylaxis of deep vein thrombosis (DVT), which ...
The patent’s assignee is Continuous Motionflow, Llc. News editors obtained the following quote from the background information supplied by the inventors: “It is estimated that more than a million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results